|
SHOC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7824700000002E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.21669999997298E-06 |
| Normal-vs-Stage2 |
2.006100E-02 |
| Normal-vs-Stage3 |
1.749170E-01 |
| Normal-vs-Stage4 |
7.003200E-01 |
| Stage1-vs-Stage2 |
2.937400E-01 |
| Stage1-vs-Stage3 |
3.911800E-02 |
| Stage1-vs-Stage4 |
8.170500E-02 |
| Stage2-vs-Stage3 |
4.957400E-01 |
| Stage2-vs-Stage4 |
4.002200E-01 |
| Stage3-vs-Stage4 |
7.235200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.58309999997996E-06 |
| Normal-vs-AfricanAmerican |
9.215800E-03 |
| Normal-vs-Asian |
8.872600E-01 |
| Caucasian-vs-AfricanAmerican |
1.374810E-01 |
| Caucasian-vs-Asian |
5.985700E-02 |
| AfricanAmerican-vs-Asian |
2.350600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.65830000018208E-07 |
| Normal-vs-Female |
4.909600E-01 |
| Male-vs-Female |
4.44450000000041E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.364200E-03 |
| Normal-vs-Extreme_Weight |
1.26929999955117E-07 |
| Normal-vs-Obese |
5.075900E-03 |
| Normal-vs-Extreme_Obese |
7.772400E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.627000E-01 |
| Normal_Weight-vs-Obese |
5.152400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.589600E-01 |
| Extreme_Weight-vs-Obese |
2.266100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.850000E-01 |
| Obese-vs-Extreme_Obese |
2.748600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.224400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.840200E-03 |
| Normal-vs-Age(61-80Yrs) |
7.80479999518136E-08 |
| Normal-vs-Age(81-100Yrs) |
1.834969999992E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.640100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.315100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.756900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.755000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.768000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.908800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.41659999997046E-06 |
| Normal-VS-Type2 PRCC |
1.69413999999701E-05 |
| Normal-VS-KIRP CIMP |
3.451800E-02 |
| Normal-VS-Unclassified PRCC |
5.969800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.339600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.87800000287453E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
2.912400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.68619999999054E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
1.855230E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.023600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.01910000000127E-06 |
| Normal-vs-N1 |
9.230400E-01 |
| Normal-vs-N2 |
5.174000E-01 |
| N0-vs-N1 |
6.989200E-04 |
| N0-vs-N2 |
3.861600E-01 |
| N1-vs-N2 |
4.837200E-01 |
|
|
